COVID-19 shot interval can be extended to 8 weeks for some -U.S. CDC

  • 📰 YahooNews
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 59%

United States Headlines News

United States Latest News,United States Headlines

Extending the interval between the first two doses of the most widely used COVID-19 vaccines in the country to eight weeks for young men can reduce the rare risk of heart inflammation, U.S. health officials said.

FILE PHOTO: Picture illustration of vials with Pfizer-BioNTech and Moderna coronavirus disease vaccine labels -

The side effect, which has been linked to both Pfizer and Moderna's COVID-19 vaccines, is higher in 12- to 39-year-old men, and therefore the eight-week interval could be optimal for some people aged 12 years and older, the U.S. Centers for Disease Control and Prevention said on Tuesday. The recommended interval between the first two shots will remain three weeks for Pfizer's vaccine and four weeks for Moderna's vaccine in other population groups, the CDC said.

Myocarditis is a rare side effect seen with mRNA vaccines - the technology behind both the Pfizer/BioNTech and Moderna shots. It appears to be more common among young men. Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commentingRecent findings show that three vaccines may be sufficient in protecting against death and severe illness for several years, mirroring SARS findings.

Source: Healthcare Press (healthcarepress.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 380. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer vaccine just 12% effective in kids ages 5 to 11, study saysResearchers with the New York State Department of Health found that the vaccine's effectiveness dropped from 68% to 12% in children aged 5 through 11 between Dec. 13 through Jan. 24.
Source: kgun9 - 🏆 584. / 51 Read more »

Pfizer Covid vaccine was just 12% effective against omicron in kids 5 to 11, study findsNY health officials found that the effectiveness of Pfizer's vaccine against Covid plummeted from 68% to 12% for children ages 5 to 11 as the omicron surged. That sucks, but in an odd way hilarious. Moderna was the best all along. couldnt find a better photo My kids say thanks for being the test babies. 🤣
Source: CNBC - 🏆 12. / 72 Read more »

COVID vaccine: US opens Pfizer, Moderna shots for kids under 5The CDC recommended COVID-19 vaccines for infants, toddlers and preschoolers on Saturday. There are no other countries in the world that give COVID shots to kids under 2 years of age. Only 2 (Cuba and Venezuela) are giving shots to kids under 3. No country gives kids under 5 mRNA shots. Dont do it ! Save kids
Source: abc13houston - 🏆 255. / 63 Read more »

CDC advisers recommend Pfizer, Moderna COVID shots for kids under 5The CDC s unanimously decided that COVID-19 vaccines should be opened to kids under 5 years of age. Disgrace! 1. Has the vaccine been update? 2. If not, why not? 3. Why would we give inferior medicine to the youngest? This is a joke. These people are somehow involved financially, there is no reason to flu jab babies!!!!
Source: ABC7Chicago - 🏆 284. / 63 Read more »

FDA OKs another Pfizer, Moderna COVID booster for 50 and upAmericans over the age of 50 are now able to get a fourth dose of Pfizer and Moderna's COVID-19 vaccine, thanks to authorization from the FDA.
Source: AKNewsNow - 🏆 460. / 53 Read more »

Pfizer and Moderna react well to cash boostersThe Covid-19 vaccine makers combined may generate an extra $110 bln through 2024. With its bounty, younger Moderna would be wise to double down on R&D. Mature Pfizer is better off pursuing acquisitions like Global Blood Therapeutics. The trick for both will be to stay focused.
Source: Breakingviews - 🏆 470. / 51 Read more »